Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stuttgart - Delayed Quote EUR

CytoDyn Inc (296.SG)

0.2500
-0.0820
(-24.70%)
At close: May 7 at 9:32:41 PM GMT+2
Currency in USD All numbers in thousands
Breakdown
TTM
5/31/2024
5/31/2023
5/31/2022
5/31/2021
Total Revenue
0
0
0
266
0
Cost of Revenue
--
0
20,633
53
0
Gross Profit
--
0
-20,633
213
0
Operating Expense
-8,093
18,058
19,943
145,617
89,520
Operating Income
8,093
-18,058
-40,576
-145,404
-89,520
Net Non Operating Interest Income Expense
-8,135
-18,173
-30,498
-61,563
-61,241
Other Income Expense
-7,044
-13,610
-8,750
-3,853
-25,704
Pretax Income
-7,086
-49,841
-79,824
-210,820
-176,465
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-8,565
-51,324
-86,736
-212,448
-178,152
Diluted NI Available to Com Stockholders
-8,565
-51,324
-86,736
-212,448
-178,152
Basic EPS
0.00
-0.05
-0.10
-0.31
-0.30
Diluted EPS
0.00
-0.05
-0.10
-0.31
-0.30
Basic Average Shares
1,149,319.2500
969,509
836,528
676,900
587,590
Diluted Average Shares
1,172,552
969,509
836,528
676,900
587,590
Total Operating Income as Reported
8,093
-18,058
-40,576
-145,404
-104,596
Total Expenses
-8,093
18,058
40,576
145,670
89,520
Net Income from Continuing & Discontinued Operation
-7,086
-49,841
-79,824
-210,820
-176,465
Normalized Income
-42
-36,231
-71,074
-206,967
-150,761
Interest Income
--
--
--
--
2
Interest Expense
5,089
5,735
6,750
15,066
61,031
Net Interest Income
-8,135
-18,173
-30,498
-61,563
-61,241
EBIT
-1,997
-44,106
-73,074
-195,754
-115,434
EBITDA
-1,979
-44,077
-72,899
-194,973
-113,637
Reconciled Cost of Revenue
--
0
20,633
53
0
Reconciled Depreciation
18
29
175
781
1,797
Net Income from Continuing Operation Net Minority Interest
-7,086
-49,841
-79,824
-210,820
-176,465
Total Unusual Items Excluding Goodwill
-7,044
-13,610
-8,750
-3,853
-25,704
Total Unusual Items
-7,044
-13,610
-8,750
-3,853
-25,704
Normalized EBITDA
5,065
-30,467
-64,149
-191,120
-87,933
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
5/31/2021 - 8/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.